News

On December 7, 2022, the Global Coalition on Aging and the Global Heart Hub convened a cross-sector roundtable of experts from healthcare, patient advocacy, policy organizations, and the private sector to discuss the challenge of heart valve disease in the context of ageing societies and their evolving needs.

In 2019, at just 33 years old, Stacey Langridge was experiencing severe shortness of breath and swollen ankles. When referred to Weston General Hospital, it was found that she had aortic stenosis, mitral valve disease and endocarditis and needed emergency treatment. Over the next four weeks in the hospital, she had her valves repaired and replaced and antibiotics to treat her endocarditis. Now, she is making a good recovery, adjusting to life after treatment, and looking forward to the future with her family.

In December, Heart Valve Voice supporter Del, challenged himself to row the distance from Brighton to London and back to raise awareness of heart valve disease and raise money for Heart Valve Voice

This week, NHS England (NHSE) issued a statement updating guidance on using TAVI to treat severe symptomatic aortic stenosis (AS). In the statement, NHSE confirms that TAVI is an alternative to surgical intervention for patients with severe symptomatic aortic stenosis who are at high surgical risk, and has extended its suitability for those at intermediate or low surgical risk, who meet the detailed inclusion criteria which accompanies the document. 

Heart Valve Voice is sad to announce the passing of our fantastic Patient Advocate, Sue Jardine.

Heart Valve Voice is delighted to mark the end of our campaign to educate half a million over 65s on heart valve disease. In 2022, we committed to teaching 500,000 over 65s about heart valve disease from detection to treatment.